News by subject: Conference

Intel Labs is showcasing some of its most significant and industry-first AI innovations at NeurIPS 2023 ? the leading global event for developers, researchers, and academic professionals focused on AI and computer-vision technologies. The event takes...

Butterfly Network, Inc. ("Butterfly") a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will participate at the 42nd Annual J.P. Morgan Healthcare Conference taking place...

Reimagine Care, the nation's leading provider of virtual and in-home cancer care, along with CU Innovations at the University of Colorado Anschutz Medical Campus (CU), a leading research institution committed to fostering innovation and excellence in...

Wharton Research Data Services (WRDS) and SSRN are pleased to announce The Chinese University of Hong Kong, Shenzhen as winner of the 2023 WRDS-SSRN Innovation Award. Annual awards are presented to rising business schools in the North America, EMEA,...

2seventy bio, Inc. , a leading immuno-oncology cell therapy company, announced today that the Company will host a conference call on Tuesday, December 12, 2023, at 8:00am ET. The event will highlight data presented at the 65th American Society of...

Seneca Therapeutics, Inc. (STI), announced today that Dr. Paul Hallenbeck will present a talk at the 8th Oncolytic Virotherapy Summit 2023 entitled "Assessing the Benefits and Challenges of Intravenous Delivery of Oncolytic Viruses". In his talk, Dr....

Regulatory News: MaaT Pharma (EURONEXT: MAAT ? the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival of patients with cancer, presented...

On December 7, 2023, the opening ceremony of the first Child-Friendly Expo (hereinafter referred to as "CFE") was held at Hall 2 of the Shenzhen Convention & Exhibition Center (Futian). Initiated by the Shenzhen Women's Federation, the CFE is the...

Bristol Myers Squibb announced the first disclosure of primary analysis results from the high-risk, second-line cohort of TRANSCEND FL, an open-label, global, multicenter, Phase 2, single-arm study evaluating Breyanzi® (lisocabtagene maraleucel,...

Positive results from the 24-week and long-term extension (LTE) period of the pivotal ALPHA Phase III trial showed danicopan as add-on to standard of care C5 inhibitor therapy ULTOMIRIS® (ravulizumab-cwvz) or SOLIRIS® (eculizumab) continued to...

Seagen Inc. today announced that clinically meaningful progression-free survival (PFS), a secondary endpoint, was observed in a Phase 2 study evaluating the antibody-drug conjugate (ADC) ADCETRIS® (brentuximab vedotin) in combination with the PD-1...

MorphoSys AG today announced comprehensive results from the Phase 3 MANIFEST-2 study investigating pelabresib, an investigational BET inhibitor, in combination with the JAK inhibitor ruxolitinib in JAK inhibitor-naïve patients with myelofibrosis....

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that new data from its CD20xCD3 T-cell engaging bispecific antibody program, including eight oral presentations, were presented at the 65th American Society of...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the latest data from InnoCare's oncology studies were presented at the 65th American...

Incyte and Syndax Pharmaceuticals today announced the full results from the pivotal Phase 2 AGAVE-201 trial of axatilimab, an anti-CSF-1R antibody, in adult and pediatric patients with refractory chronic graft-versus-host disease (GVHD) who had...

Be Biopharma, Inc. ("Be Bio"), a company pioneering the discovery and development of Engineered B Cell Medicines (BCMs), today announced results from a new preclinical study demonstrating that the company's novel engineered BCM, BE-101, produces...

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced that an abstract outlining PK and PD profiling data from the Company's ongoing Phase 1 study of...

GlycoMimetics, Inc. , a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced the 65th American Society of Hematology (ASH) Annual Meeting will feature...

Updated data from bluebird bio inc.'s gene therapy program in transfusion-dependent (TDT) beta-thalassemia were presented today at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition. Updated follow-up data showed sustained...

ImmunoGen Inc. , a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced new safety and efficacy findings from the newly diagnosed (ND) cohorts of the Phase 1b/2 study of pivekimab sunirine...

Schrödinger , whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced new preclinical data on SGR-1505, its investigational MALT1 inhibitor, and SGR-2921, its investigational CDC7...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced positive final results from the Phase 2 TELLOMAK study in Sézary Syndrome (SS). The results were presented at the ASH 2023 Annual Meeting, in San Diego,...

Pfizer Inc. today presented results from the pivotal Phase 3 BASIS clinical trial (NCT03938792) evaluating marstacimab for the treatment of people with severe hemophilia A and moderately severe to severe hemophilia B without inhibitors to Factor...

Orca Bio, a late-stage biotechnology company developing high-precision cell therapies for the treatment of cancer, autoimmune diseases and genetic blood disorders, today announced positive new data that suggest its investigational high-precision cell...

Bristol Myers Squibb announced updated results from the primary analysis of the Phase 3 COMMANDS trial, comparing Reblozyl® (luspatercept-aamt) versus epoetin alfa for the treatment of anemia in erythropoiesis stimulating agent (ESA)-naïve patients...

Rallybio Corporation , a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today presented details from the Rallybio Fetal and...

bluebird bio, Inc. ("bluebird bio" or "bluebird") today announced new and updated efficacy, safety and health-related quality of life (HRQoL) data from the Phase 1/2 HGB-206 Group C and Phase 3 HGB-210 studies of lovotibeglogene autotemcel...

Today, at COP28 in the UAE, the city of Dire Dawa (Ethiopia) Water Supply and Sewerage Authority (DDWSSA) and Nedamco Africa together with its partners Microsoft, Deltares, Hulo.ai and Isle Utilities announced the launch of the "Nedamco...

Bob's Discount Furniture, one of the fastest growing omnichannel furniture retailers in the country, recently received Furniture Today's prestigious "Furniture Industry Leadership" award for the company's value proposition, performance, and...

City of Hope, one of the largest cancer research and treatment organizations in the United States, will present innovative research at this year's San Antonio Breast Cancer Symposium (SABCS), taking place Dec. 5 to 9 in San Antonio, Texas. Each...

Ribometrix, a biotechnology company developing small molecule therapeutics that modulate RNA biology, today presented preclinical data supporting the potential of its eIF4E inhibitors in Estrogen Receptor-positive (ER+) breast cancer at the annual...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), presented today positive results from the Phase III INAVO120 study evaluating inavolisib in combination with palbociclib (Ibrance®) and fulvestrant as a first-line treatment for...

San Diego Angel Conference at the University of San Diego (SDAC) activates angel investors and connects them with early-stage companies seeking seed funding. By providing a low initial investment and robust deal flow, SDAC enables accredited...

Marchex , the award-winning AI-powered conversation intelligence company that helps businesses turn strategic insights into the actions that drive their most valued sales outcomes, today announced that CEO Edwin Miller will participate in a fireside...

ReNew Energy Global Plc ("ReNew") , India's leading renewable energy company, has been named a Clean Energy Transition Changemaker by the COP28 Presidency for its work on the Round-the-Clock Power Project. Energy Transition Changemakers is a new...

Thousands of ambulatory healthcare professionals from across the US traveled to Orlando last week to gather insights on navigating the ever-changing healthcare landscape, including how to leverage artificial intelligence (AI) to reduce provider...

Expro Group Holdings N.V. today announced that Michael Jardon, Chief Executive Officer, will participate in a panel discussion at the Goldman Sachs Energy, CleanTech and Utilities Conference at 1:40 p.m. ET on Thursday, January 4, 2024. Mr. Jardon...

South Korea-based SEMP Group and Abu Dhabi-based Global Solutions for Project Management have launched a pathbreaking innovation that will shape the future of clean energy ? the AI Smart Electromagnetic Generator (AISEG) at COP28 organized in Dubai,...

Magnetic sensor specialist startup Neuranics has announced that it will launch a magnetic sensor development kit that will record the magnetic activity of the heart and wirelessly transfer this over Bluetooth for live 24/7 recording and analysis on a...

The 28th United Nations Climate Change Conference of the Parties (COP28) is currently taking place in Dubai, UAE. The conference focuses on issues such as the global stocktake (GST), mechanism for loss and damage, whether countries are proposing more...

Archetype Entertainment, an Austin-based video game studio comprised of veteran AAA developers, took the stage at The Game Awards to provide a first look at EXODUS, their epic new sci-fi action-adventure role-playing game (RPG). The debut game from...

Seres Therapeutics, Inc. , a leading microbiome therapeutics company, announced today that preliminary clinical data from a currently enrolling Phase 1b study of SER-155 study in adult patients undergoing allogeneic hematopoietic cell transplantation...

IDEXX Laboratories, Inc. , a global leader in pet healthcare innovation, will participate in two upcoming institutional investor events: Thursday, January 4, 2024, 1:30 pm EST - Jay Mazelsky, President and Chief Executive Officer, will participate...

Johnson & Johnson will participate in the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8th, at the Westin St. Francis in San Francisco, CA. Joaquin Duato, Chairman and Chief Executive Officer will represent the Company in a...

Kamau Therapeutics ("Kamau" or "the Company"), a clinical-stage gene correction company, announced today its emergence from stealth, following a strategic transaction with Graphite Bio ("Graphite"). Under the terms of the agreement, Kamau received an...

MBrace Therapeutics, Inc. ("MBrace"), a clinical-stage biopharmaceutical company devoted to improving the lives of cancer patients through the development of antibody-drug conjugates (ADCs) against novel oncology targets, today announced new...

The 2024 NAPE Summit kicks off Wednesday, Feb. 7, when Texas Gov. Greg Abbott and Oklahoma Gov. J. Kevin Stitt share the stage to discuss all things energy in the NAPE Governors Forum: Backing American Energy. Building on the success of NAPE's...

BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, today announced the selection of four abstracts for oral presentation, four abstracts as poster presentations, and two abstracts for online publication at the 65th...

ATrack Technology Inc., a prominent player in the telematics industry, is set to join ADATA at CES 2024 to officially unveil cutting-edge innovations in the form of smart AI cameras and GPS tracking solutions. These advancements underscore a strong...

S2G Ventures ("S2G") has today announced its second investment in the leading critical minerals investment company, TechMet, which is now valued at more than $1 billion. The announcement, made at COP28, the UN Climate Change Conference being held...